Srinagar, 19 May (KNS): Regional Research Institute of Unani Medicine Srinagar under CCRUM, Ministry of Ayush has started free distribution of AYUSH-64 for asymptomatic, mild and moderate COVID-19 patients on Wednesday.

As per the press release issued to Kashmir news service (KNS), this is in continuation of the national drive for distribution of AYUSH 64 by various organisations of the Ministry of Ayush. 

The press release reads that "the COVID-19 patients who are in home isolation or are staying at isolation centres will be benefiting from this initiative of the Ministry of Ayush."

It further reads: "The Ministry of Ayush in-collaboration with CSIR has recently completed a multi-centric trial on AYUSH-64 and has found good results in safety and efficacy of this drug in the management of mild to moderate COVID-19 patients."

Further, it has revealed that the AYUSH-64 exhibit early clinical recovery in COVID-19 cases and helps protect from progression of the disease to severe or critical stage.

"AYUSH-64 comprises of poly-herbal extracts of alstonia scholaris, Picrorhiza kurroa, swertia chirata and fine powder of Caesalpinia crista. The medicine is beneficial as anti-viral, anti-pyretic and for helping in reducing the symptoms of COVID-19."

The free distribution of AYUSH-64 has reached almost all states of India including its launch today here in Srinagar. 

The effort in its distribution is expanding on a continuous basis and Sewa Bharti has volunteered its support for the distribution of  AYUSH-64 in the valley.

Speaking on the event, Dr Seema Akbar Astt Dir RRIUM Srinagar said that the distribution drive of this drug will increase in the coming days and it will benefit the COVID-19 patients of the valley. 

Further, she said that the drug can be collected from RRIUM Habak Srinagar by an attendant of any COVID-19 patient having covid positive report card as well as his Adhar card.(KNS)